The Norwegian school of veterinary science and Pharmaq have identified the virus causing cardiomyopathy syndrome (CMS), that affects Atlantic salmon. After many years of research it will be possible to control the disease and limit its spread and impact on the Atlantic salmon. Pharmaq will explore the possibilities of developing a vaccine against CMS which currently results in significant losses for the aquaculture industry in Norway. Read more...
No comments:
Post a Comment